NTGN News and Press, Neon Therapeutics Inc. From 09/06/19

Gainers : Pier 1 Imports (NYSE: PIR ) +28% . Endo International (NASDAQ: ENDP ) +24% . Autolus Therapeutics (NASDAQ: AUTL ) +25% . Microbot Medical (NASDAQ: MBOT ) +24% . Hovnanian Enterprises (NYSE: HOV ) +20% . Lannett Company (NYSE: LCI ) +20% . DocuSign (NASDAQ: DOCU ) +19% . Su...

DocuSign (NASDAQ: DOCU ) +23%  on Q2 results and analyst upgrade . More news on: DocuSign, Inc., Neon Therapeutics, Inc., Telenav, Inc., Stocks on the move, Read more ...

Thinly traded nano cap Neon Therapeutics (NASDAQ: NTGN ) is up  14%  premarket on average volume in response to a just-published paper  in the journal Immunity   supporting the value proposition of its MAPTAC mono-allelic profiling technology. More news on: Neon Ther...

Neon Therapeutics (NASDAQ: NTGN ) is up 18.6% postmarket after announcing publication in the journal Immunity of a proprietary class II prediction approach . More news on: Neon Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Proprietary class II prediction tool achieved up to a 61-fold improvement in predicting MHC class II peptides compared to standard methods Proprietary capabilities to be integrated into Neon’s RECON® bioinformatics platform to predict recruitment of CD4 + T cells to poten...

Gainers:  Net Element (NASDAQ: NETE ) +41% . Cemtrex (NASDAQ: CETX ) +20% . Pier 1 Imports (NYSE: PIR ) +18% . The Cato Corporation (NYSE: CATO ) +17% . Nordstrom (NYSE: JWN ) +16% . GameStop (NYSE: GME ) +17% . Sirius International Insurance Group (NASDAQ: SG ) +16% . Pure Sto...

Planning to present more detailed data from NT-001 clinical trial evaluating NEO-PV-01 in advanced or metastatic melanoma, non-small cell lung and bladder cancers at an upcoming medical society meeting Announces U.S. Food & Drug Administration (FDA) clearance of Neon’s Inve...

CRISPR Therapeutics ( CRSP +0.8% ) initiated with Buy rating and $72 price target at Canaccord Genuity. More news on: CRISPR Therapeutics AG, Cue Biopharma, Inc., DENTSPLY SIRONA Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Neon Therapeutics (NTGN) announced that it had achieved positive results using a personalized cancer treatment known as NEO-PV-01 in a couple types of cancer. Specifically, combining the biotech's vaccine treatment together with OPDIVO to achieve improved clinical outcomes. The combination...

Capricor Therapeutics (NASDAQ: CAPR ) +95%  on positive CAP-1002 data . More news on: Capricor Therapeutics, Inc., Galapagos NV, Neon Therapeutics, Inc., Stocks on the move, Read more ...